Authors


Millie Long, MD, MPH

Latest:

Key Takeaways and Prospective Treatment Advances

David Hudesman, MD, Maia Kayal, MD, Miguel Regueiro, MD, Anita Afzali, MD, and Millie Long summarize their discussion of Inflammatory Bowel Disease (IBD) and discuss prospective advances in treatment options.


Nicola Hanania, MD, MS

Latest:

Key Takeaways on the Evolving COPD Treatment Landscape

The panel concludes the discussion with key takeaways on the evolving treatment landscape for COPD.


Bailey Flora, MS, RD, ND

Latest:

Bariatric Surgery is Associated with Reduced Risk of Pancreatic Cancer: Analysis of a US National Database

A history of bariatric surgery was associated with up to 50% reduced risk of PDAC among a national cohort.


Seemal R. Desai, MD

Latest:

Advice for Dermatologists in Treating Psoriasis in Patients With Skin of Color

Dr Linda Stein Gold, Dr Mona Shahriari and Dr Seemal Desai share advice for improving psoriasis care for patients with skin of color.


Melodie Young, NP

Latest:

Clinical Pearls on AD Management

Andrea Nguyen, PA, shares her clinical pearls on taking care of patients with AD.


Elizabeth A. Swanson, St. Luke’s Children’s Hospital

Latest:

Emerging Agents for the Treatment of Atopic Dermatitis

Lawrence F. Eichenfield, MD; Jeffrey M. Bienstock, MD, FAAP; Peter A. Lio, MD; and Elizabeth A. Swanson, MD, review additional mechanisms being investigated in the pipeline for the treatment of atopic dermatitis.


Michael J. Thorpy, MD

Latest:

Managing Insomnia: Practical Advice for Community Physicians

Closing their discussion on insomnia, panelists share final thoughts and advice for community physicians.



Bruce Strober, MD, PhD, FAAD

Latest:

Beyond the Surface: Monitoring your Patients with Moderate to Severe Plaque Psoriasis

A panel of dermatologists have a comprehensive discussion on exciting developments in the treatment of plaque psoriasis, focusing on treatment approaches, patient monitoring strategies, and recent clinical trial data.


John Vierling, MD, FACP, FAASLD, AGAF

Latest:

Differential Diagnosis of PBC

The panel of experts focus on strategies for distinguishing primary biliary cholangitis (PBC) from other liver diseases with similar clinical presentations, emphasizing key diagnostic markers and assessment techniques.


Mary McGowan, MD, FNLA

Latest:

Clinical Pearls on Lipid Management

A panel of expert cardiologists share their clinical pearls for managing patients with hyperlipidemia.




Eugenia Gianos, MD | Credit: X.com
Eugenia Gianos, MD

Latest:

The Future of Lipoprotein Apheresis, with Laurence Sperling, MD, and Eugenia Gianos, MD

In part 3 of our Special Report on lipoprotein apheresis, Sperling and Gianos discuss future considerations for use and the evolving landscape of lipid management.


Sherry Bailey

Latest:

Physician Advice for Patients With SCD

Wally Smith, MD, shares his take-home points for patients with sickle cell disease and urges to get tested for sickle cell trait.


W. Lloyd Clark, MD

Latest:

Initiating Conversations with Patients about Anti-VEGF Agents

Key opinion leaders emphasize important considerations when discussing the safety of anti-VEGF agents with patients and highlight unmet needs in nonproliferative diabetic retinopathy treatments.


Brittany G. Craiglow, MD

Latest:

Assessing Risk and Safety of JAK Inhibitors

Panelists discuss the efficacy and safety data for ritlecitinib and deuruxolitinib in treating alopecia areata, highlighting that ritlecitinib achieved SALT scores of ≤20 in 23% of patients at week 24 compared to 1.6% in the placebo group, while deuruxolitinib showed SALT scores of ≤20 in 42.5% (8mg BID ) and 56.8% (12mg BID) of patients, with treatment-emergent adverse events primarily being mild to moderate, including upper respiratory tract infections and headaches for ritlecitinib, and headache and acne for deuruxolitinib.


Katie Robinson

Latest:

Q&A: The Role of Metabolomics in the Diagnosis of Psoriatic Arthritis

In this Q&A, Vinod Chandran, MBBS, MD, DM, PhD, discussed a method to analyze biomarkers that may differentiate patients with psoriasis and psoriatic arthritis.


Steven D. Schwartz, MD

Latest:

Overview of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema

Steven D. Schwartz, MD, reviews challenges and unmet needs in treatment of patients with neovascular AMD and DME.


Tina Bhutani, MD

Latest:

Tips for Managing Generalized Pustular Psoriasis (GPP)

Dermatologists Drs Tina Bhutani and Scott Boswell and patient Kanya Oul share resources and tools available to cope with generalized pustular psoriasis (GPP).


Arnold B. Meshkov MD, FACC

Latest:

Heart Education: Knowledge Saves Your Life

A longtime clinician writes on the signs and risks of fatal heart attack events, including the Widowmaker.


William M. Sauve, MD

Latest:

Esketamine Safety Mechanisms and Bioavailability

Geoffrey Grammer, MD closes this series highlighting the administration options of esketamine, its safety profile, and the importance of monitoring patients using this treatment.


Madelaine Feldman MD, FACR

Latest:

Challenges With Step Therapy Protocol in Treating Rheumatoid Arthritis

In this MEDcast episode, Drs Soloman, Sharobeem, Boone and Feldman discuss the use of step therapy in rheumatoid arthritis, how step therapy was intended to be used, how it is actually used, and challenges and solutions to its use.


Lawrence Eichenfield, MD

Latest:

Atopic Dermatitis: An Evolving Treatment Landscape

Closing out its discussion on atopic dermatitis, the panel considers best practices and unmet needs in the treatment landscape.


Ifeyinwa (Ify) Osunkwo, MD, MPH, Atrium Health

Latest:

Sickle Cell Disease: Unmet Needs and Future Directions in Care

Concluding their discussion on sickle cell disease management, expert panelists share key unmet needs and hopes for the future.


Anjali Tiku Owens, MD

Latest:

Real-World Insights: Navigating Cardiac Myosin inhibitors in Practice

Anjali Tiku Owens, MD, shares insights into how their institution or clinic implements the Risk Evaluation and Mitigation Strategy (REMS) program for mavacamten, detailing the requirements and responsibilities of the patient in the process. Additionally, the expert draws upon their real-world experience with the cardio myosin inhibitor (CMI) in clinical practice, providing valuable perspectives on the practical application of this novel drug class.


Gursmiran Kochhar, MD | Credit: Allegheny Health Network
Gursimran Kochhar, MD

Latest:

Appropriate Guidance for CRC Screening Age, Role of Advocacy Organizations

In part 5 of our 5-part discussion, experts discuss their perspective on appropriate guidance for screening age and the future of CRC advocacy.


Birgit H. Amann, MD

Latest:

Final Thoughts on Management of ADHD

ADHD experts share their final thoughts on the treatment and management of ADHD.


Peter Salgo, MD, Columbia University Irving Medical Center

Latest:

Final Thoughts: Awareness and Communication in Diabetes

Thought leaders in diabetes provide closing remarks about the importance of continuous awareness of glycemic control in patients as well as the need for effective communication between patients and providers. 


Michael R. DeBaun, MD, MPH, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease

Latest:

Unmet Needs in Sickle Cell Disease Management

Strategies to avoid complications of sickle cell disease and ensure non-dependency on opioids when treating patients for pain as a result of the disease.

© 2024 MJH Life Sciences

All rights reserved.